Physician profile
Griffin Becker
NPI 1184163594
$6,120.86
in general payments reported to CMS, 2019-2025
8 companies · $4,734 in 2025
The $4,734 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $191 · 2023: $114 · 2024: $1,082 · 2025: $4,734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,654 · Education: $2,500 · Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,653.76 |
| Education | $2,500.00 |
| Food and Beverage | $775.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,336.78 | 2025 | |
| Zimmer Biomet Holdings, INC. | $1,081.77 | 2024 | Advantagerib |
| Medical Device Business Services, INC. | $212.75 | 2025 | Echelon Flex |
| Smith+Nephew, INC. | $131.36 | 2022-2023 | Acticoat 4" X 4", Renasys Go V2 Home, Renasys Touch |
| Allergan, INC. | $117.25 | 2022 | |
| Boston Scientific Corporation | $112.55 | 2025 | Spyglass Discover |
| Ethicon US, LLC | $72.24 | 2025 | Surgicel Nu-Knit, Vistaseal, Echelon Flex |
| Davol INC. | $56.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Griffin Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.